413 related articles for article (PubMed ID: 29021165)
1. Preclinical modeling highlights the therapeutic potential of hematopoietic stem cell gene editing for correction of SCID-X1.
Schiroli G; Ferrari S; Conway A; Jacob A; Capo V; Albano L; Plati T; Castiello MC; Sanvito F; Gennery AR; Bovolenta C; Palchaudhuri R; Scadden DT; Holmes MC; Villa A; Sitia G; Lombardo A; Genovese P; Naldini L
Sci Transl Med; 2017 Oct; 9(411):. PubMed ID: 29021165
[TBL] [Abstract][Full Text] [Related]
2. Generation of novel Il2rg-knockout mice with clustered regularly interspaced short palindromic repeats (CRISPR) and Cas9.
Byambaa S; Uosaki H; Hara H; Nagao Y; Abe T; Shibata H; Nureki O; Ohmori T; Hanazono Y
Exp Anim; 2020 Apr; 69(2):189-198. PubMed ID: 31801915
[TBL] [Abstract][Full Text] [Related]
3. CRISPR-Cas9-AAV versus lentivector transduction for genome modification of X-linked severe combined immunodeficiency hematopoietic stem cells.
Brault J; Liu T; Liu S; Lawson A; Choi U; Kozhushko N; Bzhilyanskaya V; Pavel-Dinu M; Meis RJ; Eckhaus MA; Burkett SS; Bosticardo M; Kleinstiver BP; Notarangelo LD; Lazzarotto CR; Tsai SQ; Wu X; Dahl GA; Porteus MH; Malech HL; De Ravin SS
Front Immunol; 2022; 13():1067417. PubMed ID: 36685559
[TBL] [Abstract][Full Text] [Related]
4. Targeted genome editing restores T cell differentiation in a humanized X-SCID pluripotent stem cell disease model.
Alzubi J; Pallant C; Mussolino C; Howe SJ; Thrasher AJ; Cathomen T
Sci Rep; 2017 Sep; 7(1):12475. PubMed ID: 28963568
[TBL] [Abstract][Full Text] [Related]
5. Nuclease-free Adeno-Associated Virus-Mediated Il2rg Gene Editing in X-SCID Mice.
Hiramoto T; Li LB; Funk SE; Hirata RK; Russell DW
Mol Ther; 2018 May; 26(5):1255-1265. PubMed ID: 29606506
[TBL] [Abstract][Full Text] [Related]
6. Gene Editing of Human Hematopoietic Stem and Progenitor Cells: Promise and Potential Hurdles.
Yu KR; Natanson H; Dunbar CE
Hum Gene Ther; 2016 Oct; 27(10):729-740. PubMed ID: 27483988
[TBL] [Abstract][Full Text] [Related]
7. CRISPR-Cas9 Targeting of PCSK9 in Human Hepatocytes In Vivo-Brief Report.
Wang X; Raghavan A; Chen T; Qiao L; Zhang Y; Ding Q; Musunuru K
Arterioscler Thromb Vasc Biol; 2016 May; 36(5):783-6. PubMed ID: 26941020
[TBL] [Abstract][Full Text] [Related]
8. Restoring T and B cell generation in X-linked severe combined immunodeficiency mice through hematopoietic stem cells adenine base editing.
Zhang L; Li K; Liu Z; An L; Wei H; Pang S; Cao Z; Huang X; Jin X; Ma X
Mol Ther; 2024 Jun; 32(6):1658-1671. PubMed ID: 38532630
[TBL] [Abstract][Full Text] [Related]
9. Targeted genome editing in human repopulating haematopoietic stem cells.
Genovese P; Schiroli G; Escobar G; Tomaso TD; Firrito C; Calabria A; Moi D; Mazzieri R; Bonini C; Holmes MC; Gregory PD; van der Burg M; Gentner B; Montini E; Lombardo A; Naldini L
Nature; 2014 Jun; 510(7504):235-240. PubMed ID: 24870228
[TBL] [Abstract][Full Text] [Related]
10. Gene correction for SCID-X1 in long-term hematopoietic stem cells.
Pavel-Dinu M; Wiebking V; Dejene BT; Srifa W; Mantri S; Nicolas CE; Lee C; Bao G; Kildebeck EJ; Punjya N; Sindhu C; Inlay MA; Saxena N; DeRavin SS; Malech H; Roncarolo MG; Weinberg KI; Porteus MH
Nat Commun; 2019 Apr; 10(1):1634. PubMed ID: 30967552
[TBL] [Abstract][Full Text] [Related]
11. Genome editing for human gene therapy.
Meissner TB; Mandal PK; Ferreira LM; Rossi DJ; Cowan CA
Methods Enzymol; 2014; 546():273-95. PubMed ID: 25398345
[TBL] [Abstract][Full Text] [Related]
12. The Combination of CRISPR/Cas9 and iPSC Technologies in the Gene Therapy of Human β-thalassemia in Mice.
Ou Z; Niu X; He W; Chen Y; Song B; Xian Y; Fan D; Tang D; Sun X
Sci Rep; 2016 Sep; 6():32463. PubMed ID: 27581487
[TBL] [Abstract][Full Text] [Related]
13. Precise Gene Editing Preserves Hematopoietic Stem Cell Function following Transient p53-Mediated DNA Damage Response.
Schiroli G; Conti A; Ferrari S; Della Volpe L; Jacob A; Albano L; Beretta S; Calabria A; Vavassori V; Gasparini P; Salataj E; Ndiaye-Lobry D; Brombin C; Chaumeil J; Montini E; Merelli I; Genovese P; Naldini L; Di Micco R
Cell Stem Cell; 2019 Apr; 24(4):551-565.e8. PubMed ID: 30905619
[TBL] [Abstract][Full Text] [Related]
14. Non-viral
Byambaa S; Uosaki H; Ohmori T; Hara H; Endo H; Nureki O; Hanazono Y
Mol Ther Methods Clin Dev; 2021 Mar; 20():451-462. PubMed ID: 33614821
[TBL] [Abstract][Full Text] [Related]
15. The TRACE-Seq method tracks recombination alleles and identifies clonal reconstitution dynamics of gene targeted human hematopoietic stem cells.
Sharma R; Dever DP; Lee CM; Azizi A; Pan Y; Camarena J; Köhnke T; Bao G; Porteus MH; Majeti R
Nat Commun; 2021 Jan; 12(1):472. PubMed ID: 33473139
[TBL] [Abstract][Full Text] [Related]
16. HIF-1α-stabilizing agent FG-4497 rescues human CD34
Nowlan B; Futrega K; Brunck ME; Walkinshaw G; Flippin LE; Doran MR; Levesque JP
Exp Hematol; 2017 Aug; 52():50-55.e6. PubMed ID: 28527810
[TBL] [Abstract][Full Text] [Related]
17. Combined lentiviral- and RNA-mediated CRISPR/Cas9 delivery for efficient and traceable gene editing in human hematopoietic stem and progenitor cells.
Yudovich D; Bäckström A; Schmiderer L; Žemaitis K; Subramaniam A; Larsson J
Sci Rep; 2020 Dec; 10(1):22393. PubMed ID: 33372184
[TBL] [Abstract][Full Text] [Related]
18. Cellular function reinstitution of offspring red blood cells cloned from the sickle cell disease patient blood post CRISPR genome editing.
Wen J; Tao W; Hao S; Zu Y
J Hematol Oncol; 2017 Jun; 10(1):119. PubMed ID: 28610635
[TBL] [Abstract][Full Text] [Related]
19. Gene targeting technologies in rats: zinc finger nucleases, transcription activator-like effector nucleases, and clustered regularly interspaced short palindromic repeats.
Mashimo T
Dev Growth Differ; 2014 Jan; 56(1):46-52. PubMed ID: 24372523
[TBL] [Abstract][Full Text] [Related]
20. Efficient ablation of genes in human hematopoietic stem and effector cells using CRISPR/Cas9.
Mandal PK; Ferreira LM; Collins R; Meissner TB; Boutwell CL; Friesen M; Vrbanac V; Garrison BS; Stortchevoi A; Bryder D; Musunuru K; Brand H; Tager AM; Allen TM; Talkowski ME; Rossi DJ; Cowan CA
Cell Stem Cell; 2014 Nov; 15(5):643-52. PubMed ID: 25517468
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
